October 30, 2026

Ammar Sabilarrohman

Lilly’s Novel JAK2 Inhibitor Shows Promising Early Results in Myelofibrosis, Offering New Hope for Patients lillys-novel-jak2-inhibitor-shows-promising-early-results-in-myelofibrosis-offering-new-hope-for-patients

Lilly’s Novel JAK2 Inhibitor Shows Promising Early Results in Myelofibrosis, Offering New Hope for Patients

Ammar Sabilarrohman June 15, 2026
Indianapolis, IN – June 15, 2026 – Eli Lilly and Company has unveiled encouraging Phase I data...
Read More Read more about Lilly’s Novel JAK2 Inhibitor Shows Promising Early Results in Myelofibrosis, Offering New Hope for Patients
Unlocking the Genetic Blueprint: How a New Sorghum Pangenome is Revolutionizing Global Agriculture unlocking-the-genetic-blueprint-how-a-new-sorghum-pangenome-is-revolutionizing-global-agriculture

Unlocking the Genetic Blueprint: How a New Sorghum Pangenome is Revolutionizing Global Agriculture

Ammar Sabilarrohman June 15, 2026
In the quiet laboratories of the HudsonAlpha Institute for Biotechnology, a quiet revolution is taking place—one that...
Read More Read more about Unlocking the Genetic Blueprint: How a New Sorghum Pangenome is Revolutionizing Global Agriculture
A Test of Resilience: International Student’s Journey Through Breast Cancer Becomes a Beacon of Hope a-test-of-resilience-international-students-journey-through-breast-cancer-becomes-a-beacon-of-hope

A Test of Resilience: International Student’s Journey Through Breast Cancer Becomes a Beacon of Hope

Ammar Sabilarrohman June 15, 2026
Columbia, SC – Joy, a 31-year-old international student, arrived in the United States in 2023 with a...
Read More Read more about A Test of Resilience: International Student’s Journey Through Breast Cancer Becomes a Beacon of Hope
The Future of AI in UK Healthcare: Regulatory Overhaul Looms as Stakeholders Demand Greater Safety and Transparency the-future-of-ai-in-uk-healthcare-regulatory-overhaul-looms-as-stakeholders-demand-greater-safety-and-transparency

The Future of AI in UK Healthcare: Regulatory Overhaul Looms as Stakeholders Demand Greater Safety and Transparency

Ammar Sabilarrohman June 14, 2026
The integration of artificial intelligence (AI) into the National Health Service (NHS) and the broader UK healthcare...
Read More Read more about The Future of AI in UK Healthcare: Regulatory Overhaul Looms as Stakeholders Demand Greater Safety and Transparency
A Call for Ceasefire and Solidarity: Dr. Tedros Adhanom Ghebreyesus Appeals to Ituri Amid New Ebola Crisis a-call-for-ceasefire-and-solidarity-dr-tedros-adhanom-ghebreyesus-appeals-to-ituri-amid-new-ebola-crisis

A Call for Ceasefire and Solidarity: Dr. Tedros Adhanom Ghebreyesus Appeals to Ituri Amid New Ebola Crisis

Ammar Sabilarrohman June 14, 2026
Introduction: A Personal Plea from the Heart of the DRC In an impassioned and deeply personal appeal...
Read More Read more about A Call for Ceasefire and Solidarity: Dr. Tedros Adhanom Ghebreyesus Appeals to Ituri Amid New Ebola Crisis

You may have missed

landmark-cambridge-study-reveals-life-saving-benefits-of-ovarian-removal-for-brca-carriers-with-breast-cancer

Landmark Cambridge Study Reveals Life-Saving Benefits of Ovarian Removal for BRCA Carriers with Breast Cancer

Sagoh October 30, 2026
a-paradigm-shift-in-oncology-bcrf-symposium-unveils-revolutionary-advances-in-ai-fertility-and-the-biology-of-aging

A Paradigm Shift in Oncology: BCRF Symposium Unveils Revolutionary Advances in AI, Fertility, and the Biology of Aging

Pevita Pearce October 30, 2026
the-silent-killer-whos-landmark-report-calls-for-urgent-global-action-against-hypertension

The Silent Killer: WHO’s Landmark Report Calls for Urgent Global Action Against Hypertension

Ali Ikhwan October 30, 2026
from-acquisition-to-innovation-the-strategic-rebirth-of-actio-as-setara-biosciences

From Acquisition to Innovation: The Strategic Rebirth of Actio as Setara Biosciences

Lina Irawan October 30, 2026